Detection performance and prognostic value of initial bone marrow involvement in diffuse large B-cell lymphoma: a single centre ¹⁸F-FDG PET/CT and bone marrow biopsy evaluation study

1. Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med 2021; 384: 842–58. doi: 10.1056/NEJMra2027612 SehnLH SallesG Diffuse large B-cell lymphoma N Engl J Med 2021 384 842 58 10.1056/NEJMra2027612 Open DOISearch in Google Scholar

2. Cheson BD, Ansell S, Schwartz L, Gordon LI, Advani R, Jacene HA, et al. Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy. Blood 2016; 128: 2489–96. doi: 10.1182/blood-2016-05-718528 ChesonBD AnsellS SchwartzL GordonLI AdvaniR JaceneHA Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy Blood 2016 128 2489 96 10.1182/blood-2016-05-718528 Open DOISearch in Google Scholar

3. Sehn LH, Scott DW, Chhanabhai M, Berry B, Ruskova A, Berkahn L, et al. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol 2011; 29: 1452–7. doi: 10.1200/JCO.2010.33.3419 SehnLH ScottDW ChhanabhaiM BerryB RuskovaA BerkahnL Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP J Clin Oncol 2011 29 1452 7 10.1200/JCO.2010.33.3419 Open DOISearch in Google Scholar

4. Adams HJ, Nievelstein RA, Kwee TC. Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma. Blood Rev 2015; 29: 417–25. doi: 10.1016/j.blre.2015.06.003 AdamsHJ NievelsteinRA KweeTC Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma Blood Rev 2015 29 417 25 10.1016/j.blre.2015.06.003 Open DOISearch in Google Scholar

5. Khan AB, Barrington SF, Mikhaeel NG, Hunt AA, Cameron L, Morris T, et al. PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement. Blood 2013; 122: 61–7. doi: 10.1182/blood-2012-12-473389 KhanAB BarringtonSF MikhaeelNG HuntAA CameronL MorrisT PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement Blood 2013 122 61 7 10.1182/blood-2012-12-473389 Open DOISearch in Google Scholar

6. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 2014; 32: 3059–68. doi: 10.1200/JCO.2013.54.8800 ChesonBD FisherRI BarringtonSF CavalliF SchwartzLH ZuccaE Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification J Clin Oncol 2014 32 3059 68 10.1200/JCO.2013.54.8800 Open DOISearch in Google Scholar

7. Bain BJ. Bone marrow biopsy morbidity and mortality. Br J Haematol 2003; 121: 949–51. doi: 10.1046/j.1365-2141.2003.04329.x BainBJ Bone marrow biopsy morbidity and mortality Br J Haematol 2003 121 949 51 10.1046/j.1365-2141.2003.04329.x Open DOISearch in Google Scholar

8. Basu S, Alavi A. SPECT-CT and PET-CT in oncology – an overview. Curr Med Imaging Rev 2011; 7: 202–9. doi: 10.2174/157340511796411168 BasuS AlaviA SPECT-CT and PET-CT in oncology – an overview Curr Med Imaging Rev 2011 7 202 9 10.2174/157340511796411168 Open DOISearch in Google Scholar

9. Berthet L, Cochet A, Kanoun S, Berriolo-Riedinger A, Humbert O, Toubeau M, et al. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with ¹⁸F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy. J Nucl Med 2013; 54: 1244–50. doi: 10.2967/jnumed.112.114710 BerthetL CochetA KanounS Berriolo-RiedingerA HumbertO ToubeauM In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with ¹⁸F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy J Nucl Med 2013 54 1244 50 10.2967/jnumed.112.114710 Open DOISearch in Google Scholar

10. El Karak F, Bou-Orm IR, Ghosn M, Kattan J, Farhat F, Ibrahim T, et al. PET/CT scanner and bone marrow biopsy in detection of bone marrow involvement in diffuse large B-cell lymphoma. PLoS One 2017; 12: e0170299. doi: 10.1371/journal.pone.0170299 El KarakF Bou-OrmIR GhosnM KattanJ FarhatF IbrahimT PET/CT scanner and bone marrow biopsy in detection of bone marrow involvement in diffuse large B-cell lymphoma PLoS One 2017 12 e0170299 10.1371/journal.pone.0170299 Open DOISearch in Google Scholar

11. Hao B, Zhao L, Luo NN, Ruan D, Pang YZ, Guo W, et al. Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using ¹⁸F-FDG PET/CT and/or routine iliac crest biopsy? A new approach of PET/CT-guided targeted bone marrow biopsy. BMC Cancer 2018; 18: 1192. doi: 10.1186/s12885-018-5104-0 HaoB ZhaoL LuoNN RuanD PangYZ GuoW Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using ¹⁸F-FDG PET/CT and/or routine iliac crest biopsy? A new approach of PET/CT-guided targeted bone marrow biopsy BMC Cancer 2018 18 1192 10.1186/s12885-018-5104-0 Open DOISearch in Google Scholar

12. Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 2015; 42: 328–54. doi: 10.1007/s00259-014-2961-x BoellaardR Delgado-BoltonR OyenWJ GiammarileF TatschK EschnerW FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 Eur J Nucl Med Mol Imaging 2015 42 328 54 10.1007/s00259-014-2961-x Open DOISearch in Google Scholar

13. Lee SH, Erber WN, Porwit A, Tomonaga M, Peterson LC. International Council for Standardization in hematology. ICSH guidelines for the standardization of bone marrow specimens and reports. Int J Lab Hematol 2008; 30: 349–64. doi: 10.1111/j.1751-553X.2008.01100.x LeeSH ErberWN PorwitA TomonagaM PetersonLC International Council for Standardization in hematology. ICSH guidelines for the standardization of bone marrow specimens and reports Int J Lab Hematol 2008 30 349 64 10.1111/j.1751-553X.2008.01100.x Open DOISearch in Google Scholar

14. Brozic A, Pohar Marinsek Z, Novakovic S, Kloboves Prevodnik V. Inconclusive flow cytometric surface light chain results; can cytoplasmic light chains, Bcl-2 expression and PCR clonality analysis improve accuracy of cytological diagnoses in B-cell lymphomas? Diagn Pathol 2015; 10: 191. doi: 10.1186/s13000-015-0427-5 BrozicA Pohar MarinsekZ NovakovicS Kloboves PrevodnikV Inconclusive flow cytometric surface light chain results; can cytoplasmic light chains, Bcl-2 expression and PCR clonality analysis improve accuracy of cytological diagnoses in B-cell lymphomas? Diagn Pathol 2015 10 191 10.1186/s13000-015-0427-5 Open DOISearch in Google Scholar

15. Brožič A. [Clonality and antigenic properties of reactive and neoplastic lymphocytic proliferations]. [Slovenian]. [Doctoral dissertation]. Ljubljana: University of Ljubljana. [cited 2023 Jul 27]. Available at: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=slv&id=84423 BrožičA [Clonality and antigenic properties of reactive and neoplastic lymphocytic proliferations]. [Slovenian]. [Doctoral dissertation] Ljubljana University of Ljubljana [cited 2023 Jul 27]. Available at: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=slv&id=84423 Search in Google Scholar

16. Salaun PY, Gastinne T, Bodet-Milin C, Campion L, Cambefort P, Moreau, et al. Analysis of ¹⁸F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin’s lymphoma: a reflection of disease infiltration or just inflammation? Eur J Nucl Med Mol Imaging 2009; 36: 1813–21. doi: 10.1007/s00259-009-1183-0 SalaunPY GastinneT Bodet-MilinC CampionL CambefortP Moreau Analysis of ¹⁸F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin’s lymphoma: a reflection of disease infiltration or just inflammation? Eur J Nucl Med Mol Imaging 2009 36 1813 21 10.1007/s00259-009-1183-0 Open DOISearch in Google Scholar

17. Zwarthoed C, El-Galaly TC, Canepari M, Ouvrier MJ, Viotti J, Ettaiche M, et al. Prognostic value of bone marrow tracer uptake pattern in baseline PET scans in Hodgkin lymphoma: results from an International Collaborative Study. J Nucl Med 2017; 58: 1249–54. doi: 10.2967/jnumed.116.184218 ZwarthoedC El-GalalyTC CanepariM OuvrierMJ ViottiJ EttaicheM Prognostic value of bone marrow tracer uptake pattern in baseline PET scans in Hodgkin lymphoma: results from an International Collaborative Study J Nucl Med 2017 58 1249 54 10.2967/jnumed.116.184218 Open DOISearch in Google Scholar

18. Tilly H, Gomes da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A, et al. ESMO Guidelines Committee. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015; 26: v116–25. doi: 10.1093/annonc/mdv304 TillyH Gomes da SilvaM VitoloU JackA MeignanM Lopez-GuillermoA ESMO Guidelines Committee. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 2015 26 v116 25 10.1093/annonc/mdv304 Open DOISearch in Google Scholar

19. Wang J, Weiss LM, Chang KL, Slovak ML, Gaal K, Forman SJ, et al. Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy. Cancer 2002; 94: 1522–31. doi: 10.1002/cncr.10364 WangJ WeissLM ChangKL SlovakML GaalK FormanSJ Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy Cancer 2002 94 1522 31 10.1002/cncr.10364 Open DOISearch in Google Scholar

20. Salem P, Wolverson MK, Reimers HJ, Kudva GC. Complications of bone marrow biopsy. Br J Haematol 2003; 121: 821. doi: 10.1046/j.1365-2141.2003.04328.x SalemP WolversonMK ReimersHJ KudvaGC Complications of bone marrow biopsy Br J Haematol 2003 121 821 10.1046/j.1365-2141.2003.04328.x Open DOISearch in Google Scholar

21. Vieira L, Pires A, Grilo A. Anxiety experienced by oncological patients who undergo ¹⁸F-FDG PET CT: a systematic review. Radiography 2021; 27: 1203–10. doi: 10.1016/j.radi.2021.06.001 VieiraL PiresA GriloA Anxiety experienced by oncological patients who undergo ¹⁸F-FDG PET CT: a systematic review Radiography 2021 27 1203 10 10.1016/j.radi.2021.06.001 Open DOISearch in Google Scholar

22. Elamir Y, Elazab M, Owis AS, Elsayed HF. PET/CT and bone marrow biopsy (BMB) in evaluating bone marrow in lymphoma. Egypt J Radiol Nucl Med 2020; 51: 201. doi: 10.1186/s43055-020-00318-8 ElamirY ElazabM OwisAS ElsayedHF PET/CT and bone marrow biopsy (BMB) in evaluating bone marrow in lymphoma Egypt J Radiol Nucl Med 2020 51 201 10.1186/s43055-020-00318-8 Open DOISearch in Google Scholar

23. Büyükşimşek M, Kolsuz İ, Yetişir AE, Tohumcuoğlu M, Oğul A, Mirili C, et al. Performance of positron emission tomography-computed tomography and bone marrow biopsy in detecting bone marrow infiltration in lymphoma cases. Turk J Haematol 2020; 37: 220–25. doi: 10.4274/tjh.galenos.2020.2019.0361 BüyükşimşekM Kolsuzİ YetişirAE TohumcuoğluM OğulA MiriliC Performance of positron emission tomography-computed tomography and bone marrow biopsy in detecting bone marrow infiltration in lymphoma cases Turk J Haematol 2020 37 220 25 10.4274/tjh.galenos.2020.2019.0361 Open DOISearch in Google Scholar

24. Pelosi E, Penna D, Douroukas A, Bellò M, Amati A, Arena V, et al. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study. Q J Nucl Med Mol Imaging 2011; 55: 469–75. PMID: 21150862 PelosiE PennaD DouroukasA BellòM AmatiA ArenaV Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study Q J Nucl Med Mol Imaging 2011 55 469 75 21150862 Search in Google Scholar

25. Kandeel AA, Hussein M, Zidan L, Younis J, Edesa W, Alsayed Y. Diagnostic performance of ¹⁸F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma. Nucl Med Commun 2020; 41: 269–79. doi: 10.1097/MNM.0000000000001139 KandeelAA HusseinM ZidanL YounisJ EdesaW AlsayedY Diagnostic performance of ¹⁸F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma Nucl Med Commun 2020 41 269 79 10.1097/MNM.0000000000001139 Open DOISearch in Google Scholar

26. Almaimani J, Tsoumpas C, Feltbower R, Polycarpou I. FDG PET/CT versus bone marrow biopsy for diagnosis of bone marrow involvement in non-hodgkin lymphoma: a systematic review. Applied Sciences 2022; 12: 540. doi: 10.3390/app12020540 AlmaimaniJ TsoumpasC FeltbowerR PolycarpouI FDG PET/CT versus bone marrow biopsy for diagnosis of bone marrow involvement in non-hodgkin lymphoma: a systematic review Applied Sciences 2022 12 540 10.3390/app12020540 Open DOISearch in Google Scholar

27. Chang JM, Lee HJ, Goo JM, Lee HY, Lee JJ, Chung JK, et al. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J Radiol 2006; 7: 57–69. doi: 10.3348/kjr.2006.7.1.57 ChangJM LeeHJ GooJM LeeHY LeeJJ ChungJK False positive and false negative FDG-PET scans in various thoracic diseases Korean J Radiol 2006 7 57 69 10.3348/kjr.2006.7.1.57 Open DOISearch in Google Scholar

28. Aoki J, Watanabe H, Shinozaki T, Takagishi K, Ishijima H, Oya N, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001; 219: 774–7. AokiJ WatanabeH ShinozakiT TakagishiK IshijimaH OyaN FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions Radiology 2001 219 774 7 Search in Google Scholar

29. Yao Z, Deng L, Xu-Monette ZY, Manyam GC, Jain P, Tzankov A, et al. Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy. Leukemia 2018; 32: 353–63. doi: 10.1038/leu.2017.222. YaoZ DengL Xu-MonetteZY ManyamGC JainP TzankovA Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy Leukemia 2018 32 353 63 10.1038/leu.2017.222 Open DOISearch in Google Scholar

30. Alonso-Álvarez S, Alcoceba M, García-Álvarez M, Blanco O, Rodríguez M, Baile M, et al. Biological features and prognostic impact of bone marrow infiltration in patients with diffuse large b-cell lymphoma. Cancers 2020; 12: 474. doi: 10.3390/cancers12020474 Alonso-ÁlvarezS AlcocebaM García-ÁlvarezM BlancoO RodríguezM BaileM Biological features and prognostic impact of bone marrow infiltration in patients with diffuse large b-cell lymphoma Cancers 2020 12 474 10.3390/cancers12020474 Open DOISearch in Google Scholar

31. Horvat M, Zadnik V, Južnič Šetina T, Boltežar L, Pahole Goličnik J, Novaković S, et al. Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone. Oncol Lett 2018; 15: 3602–9. doi: 10.3892/ol.2018.7774 HorvatM ZadnikV Južnič ŠetinaT BoltežarL Pahole GoličnikJ NovakovićS Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone Oncol Lett 2018 15 3602 9 10.3892/ol.2018.7774 Open DOISearch in Google Scholar